rewirebio.iobenchmarks
Dataset

Davis holdout test fold (DeepDTA split)

Davis kinase inhibitor selectivity dataset: 442 kinases, 68 inhibitors, 30,056 pairs; Kd log-transformed to pKd following He et al. 2017; predefined DeepDTA holdout test fold. Evaluated on the corrected version with mutant sequences resolved (Appendix A); not the commonly used DeepDTA repository sequences.

Evaluation results

16 evaluations · 32 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: DeepDTA with 1D conv. protein and 1D conv. drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.902 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepDTA (1D conv.; 1D conv.) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepDTA' with protein '1D conv.' and drug '1D conv.', column 'CI' (text-layer line 529)
Configuration: DeepDTA with 1D conv. protein and 1D conv. drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.224 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DeepDTA (1D conv.; 1D conv.) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepDTA' with protein '1D conv.' and drug '1D conv.', column 'MSE' (text-layer line 529)
Configuration: DeepGraphDTA with 1D conv. (16) protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.907 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (16); GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (16)' and drug 'GAT', column 'CI' (text-layer line 534)
Configuration: DeepGraphDTA with 1D conv. (16) protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.176 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (16); GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (16)' and drug 'GAT', column 'MSE' (text-layer line 534)
Configuration: DeepGraphDTA with 1D conv. (16) protein and GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.906 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (16); GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (16)' and drug 'GCN', column 'CI' (text-layer line 533)
Configuration: DeepGraphDTA with 1D conv. (16) protein and GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.174 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (16); GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (16)' and drug 'GCN', column 'MSE' (text-layer line 533)
Configuration: DeepGraphDTA with 1D conv. (32) protein and GIN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.909 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (32); GIN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (32)' and drug 'GIN', column 'CI' (text-layer line 536)
Configuration: DeepGraphDTA with 1D conv. (32) protein and GIN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.172 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (32); GIN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (32)' and drug 'GIN', column 'MSE' (text-layer line 536)
Configuration: DeepGraphDTA with 1D conv. (8) protein and GAT-GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.906 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (8); GAT-GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (8)' and drug 'GAT-GCN', column 'CI' (text-layer line 532)
Configuration: DeepGraphDTA with 1D conv. (8) protein and GAT-GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.175 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

DeepGraphDTA (1D conv. (8); GAT-GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'DeepGraphDTA' with protein '1D conv. (8)' and drug 'GAT-GCN', column 'MSE' (text-layer line 532)
Configuration: GraphDTA with 1D conv. protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.893 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GAT', column 'CI' (text-layer line 526)
Configuration: GraphDTA with 1D conv. protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.255 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GAT', column 'MSE' (text-layer line 526)
Configuration: GraphDTA with 1D conv. protein and GAT-GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.889 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT-GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GAT-GCN', column 'CI' (text-layer line 525)
Configuration: GraphDTA with 1D conv. protein and GAT-GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.227 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GAT-GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GAT-GCN', column 'MSE' (text-layer line 525)
Configuration: GraphDTA with 1D conv. protein and GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.88 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GCN', column 'CI' (text-layer line 523)
Configuration: GraphDTA with 1D conv. protein and GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.237 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GCN', column 'MSE' (text-layer line 523)
Configuration: GraphDTA with 1D conv. protein and GIN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.897 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GIN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GIN', column 'CI' (text-layer line 527)
Configuration: GraphDTA with 1D conv. protein and GIN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.199 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

GraphDTA (1D conv.; GIN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'GraphDTA' with protein '1D conv.' and drug 'GIN', column 'MSE' (text-layer line 527)
Configuration: KronRLS with Similarity vector protein and Similarity vector drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.87 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

KronRLS (Similarity vector; Similarity vector) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'KronRLS' with protein 'Similarity vector' and drug 'Similarity vector', column 'CI' (text-layer line 522)
Configuration: KronRLS with Similarity vector protein and Similarity vector drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.359 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

KronRLS (Similarity vector; Similarity vector) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'KronRLS' with protein 'Similarity vector' and drug 'Similarity vector', column 'MSE' (text-layer line 522)
Configuration: PGraphDTA with ESM2 650M protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.898 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

PGraphDTA (ESM2 650M; GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'PGraphDTA' with protein 'ESM2 650M' and drug 'GAT', column 'CI' (text-layer line 528)
Configuration: PGraphDTA with ESM2 650M protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.206 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

PGraphDTA (ESM2 650M; GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'PGraphDTA' with protein 'ESM2 650M' and drug 'GAT', column 'MSE' (text-layer line 528)
Configuration: PLM-GraphDTA with ESMC 600M protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.908 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PLM-GraphDTA (ESMC 600M; GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'PLM-GraphDTA' with protein 'ESMC 600M' and drug 'GAT', column 'CI' (text-layer line 535)
Configuration: PLM-GraphDTA with ESMC 600M protein and GAT drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.174 MSE (Davis DeepDTA holdout fold)
unit-unreported · lower

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PLM-GraphDTA (ESMC 600M; GAT) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'PLM-GraphDTA' with protein 'ESMC 600M' and drug 'GAT', column 'MSE' (text-layer line 535)
Configuration: PLM-GraphDTA with ESMC 600M protein and GAT-GCN drug representationProtocol: Davis drug-target affinity, DeepDTA holdout fold
Dataset: Davis holdout test fold (DeepDTA split)
0.91 Concordance index (Davis DeepDTA holdout fold)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PLM-GraphDTA (ESMC 600M; GAT-GCN) on Davis

lit-interactions-20261011-plmdta-protocol-davis-deepdta-holdout

Aggregation: Not reported

Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction · Table 2, row 'PLM-GraphDTA' with protein 'ESMC 600M' and drug 'GAT-GCN', column 'CI' (text-layer line 538)

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

5 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Source location
Section 3.1.1; Section 3.4
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.1; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Split
Predefined DeepDTA holdout test fold (train:test 5:1)
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.1; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.split

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
Davis as corrected by Monteiro et al. 2022 (mutant sequences resolved; Appendix A), DeepDTA folds
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.1; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: attributes.version

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Davis kinase inhibitor selectivity dataset: 442 kinases, 68 inhibitors, 30,056 pairs; Kd log-transformed to pKd following He et al. 2017; predefined DeepDTA holdout test fold. Evaluated on the corrected version with mutant sequences resolved (Appendix A); not the commonly used DeepDTA repository sequences.
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.1; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: description

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
Davis holdout test fold (DeepDTA split)
Context-only references
Comprehensive Evaluation of Protein Language Model Embeddings for Drug-Target Affinity Prediction

Original source ↗

Section 3.1.1; Section 3.4

Version: bioRxiv 10.64898/2026.08.31.748056v1 (posted 2026-09-03); 24-page PDF
Retrieved: 2026-10-11T21:27:40Z

not individually reviewed

No individual claim review recorded

Source has a recorded evidence concern. Consult its source page before using the claim.

Audit details

Field: name

Source artifact SHA-256: 11b88d5ab2964b581430454d0d9e7848739819d52ec2e338e2a6412cbd259163

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: lit-interactions-20261011-plmdta-data-davis-deepdta-holdout

areas
molecular-interactions
contexts
research
version
Davis as corrected by Monteiro et al. 2022 (mutant sequences resolved; Appendix A), DeepDTA folds
split
Predefined DeepDTA holdout test fold (train:test 5:1)
source locator
Section 3.1.1; Section 3.4
Related records

Suggest a correction